Cor Vasa 2007, 49(6):209-211

Pozdní trombózy lékových stentů - zanedbatelný problém nebo konec velké naděje? Racionální přístup k lékovým stentům

Jan Vojáček
I. interní klinika, Fakultní nemocnice Hradec Králové a Lékařská fakulta Univerzity Karlovy, Hradec Králové, Česká republika

Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vojáček J. Pozdní trombózy lékových stentů - zanedbatelný problém nebo konec velké naděje? Racionální přístup k lékovým stentům. Cor Vasa. 2007;49(6):209-211.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Serruys PW, Daemen J. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis. A nuisance in both bare metal and drug-eluting stents. Circulation 2007; 115:1433-9. Go to original source... Go to PubMed...
    2. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369(9562):667-78. Go to original source... Go to PubMed...
    3. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. for BASKET-LATE Investigators Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents. An Observational Study of Drug-Eluting Versus Bare-Metal Stents. J Am Coll Cardiol 2006;48:2584-91. Go to original source... Go to PubMed...
    4. Lagerqvist B, James, SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. for the SCAAR study group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. New Engl J Med 2007; 356:1009-18. Go to original source... Go to PubMed...
    5. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with baremetals stents. New Engl J Med 2007;356:1030-9. Go to original source... Go to PubMed...
    6. Maisel WH. Unanswered questions - drug-eluting stents and the risk of late thrombosis. New Engl J Med 2007; 356:981-4. Go to original source... Go to PubMed...
    7. Farb A, Boam AB. Stent thrombosis redux - the FDA perspective. New Engl J Med 2007;356:984-7. Go to original source... Go to PubMed...
    8. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus eluting stents with bare metal stents. New Engl J Med 2007;356:989-97. Go to original source... Go to PubMed...
    9. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113:2803-9. Go to original source... Go to PubMed...
    10. Takano M, Ohba T, Inami S, Seimiya K, Sakai S, Mizuno K. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation. Eur Heart J 2006;27:2189-95. Go to original source... Go to PubMed...
    11. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. J Am Med Ass 2007;297:159-68. Go to original source... Go to PubMed...
    12. Rocca HP, Kaiser C, Pfisterer M. Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET). Eur Heart J 2007; 28:719-25. Go to original source... Go to PubMed...
    13. Vojáček J. Jak dále s lékovými stenty (DES)? Interv Akut Kardiol 2006;5:239.
    14. Želízko M. Lékové stenty - kritický pohled na kritiku. Interv Akut Kardiol 2007;6:39-40.

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes